A case of parathyroid carcinoma is described which presented with severe bone disease, complicated after parathyroidectomy by symptomatic hypocalcaemia and magnesium deficiency, both of which responded dramatically to the administration of magnesium. Urinary cyclic AMP assays were used to monitor parathyroid activity.
Get full access to this article
View all access options for this article.
References
1.
AnastC. S., MohsJ. M., KaplanS. L., BurnsT. W. (1972). Evidence for parathyroid failure in magnesium deficiency. Science, 177, 606.
2.
BuckleR. M., CareA. D., CooperC. W., GitelmanH. J. (1968). The influence of plasma magnesium concentration on parathyroid hormone secretion. Journal of Endocrinology, 42, 529.
3.
ChaseL. R., SlatopolskyE. (1974). Secretion and metabolic efficacy of parathyroid hormone in patients with severe hypomagnesaemia. Journal of Clinical Endocrinology and Metabolism, 38, 363.
4.
ConnorT. B., ToskerP., MahaffeyJ., MartinL. G., WilliamsJ. B., WalserM. (1972). Parathyroid function during chronic magnesium deficiency. John Hopkins Medical Journal, 131, 100.
5.
DentC. E. (1962). Some problems of hyperparathyroidism. British Medical Journal, 2, 1419.
6.
GaleT. C., OwensC. W. I. (1972). Hyperfunctioning carcinoma of the parathyroid gland. Postgraduate Medical Journal, 48, 626.
HorstingM., De LucaH. (1969). In vitro production of 25-hydroxycholecalciferol. Biochemical and Biophysical Communications, 36, 251.
9.
JonesC. T. A., SellwoodR. A., EvansonJ. M. (1973). Symptomatic hypomagnesaemia after parathyroidectomy. British Medical Journal, 3, 391.
10.
KaminskyN. I., BroadusA. E., HardmanJ. G., JonesD. J., BallJ. H., SutherlandE. W., LiddleG. W. (1970). Effects of parathyroid hormone on plasma and urinary cyclic AMP in man. Journal of Clinical investigation, 49, 2387.
11.
PakC. Y. C., De LucaH. F., Chavez de los RiosJ. M., SudaT., RuskinB., DeleaC. A. (1970). Treatment of vitamin D resistant hypoparathyroidism with 25-hydroxycholecalciferol. Archives of Internal Medicine, 126, 239.
12.
PakC. Y. C., DillerE. C. (1969). Ionic interaction in the bone mineral v. effect of Mg, Citrate, F and SO4 ions on the solubility dissolution and growth of bone mineral. Calcified Tissue Research, 4, 69.
13.
RosierA., RabinowitzD. (1973). Magnesium induced reversal of vitamin D resistance in hypoparathyroidism. Lancet, 1, 803.
14.
SherwoodL. M., HerrmanI., BassettC. A. (1970. Parathyroid hormone secretion in vitro: regullation by calcium and magnesium ions. Nature, 225, 1056.
15.
SubS. M., TashjianA. H., MatsuoN., ParkinsonD. K., FraserD. (1973). Pathogenesis of hypocalcaemia in primary hypomagnesaemia: normal end-organ responsiveness to parathyroid hormone, impaired parathyroid gland function. Journal of Clinical Investigation, 52, 153.
16.
TargovnikJ. H., RodmanJ. S., SherwoodL. M. (1971). Regulation of parathyroid hormone secretion in vitro: Quantitative aspects of calcium and magnesium ion control. Endicrinology, 88, 1477.
17.
TaylorA. L., DavisB. B., PawlsonL. G., JosimovitchJ. B., MintzD. H. (1970). Factors influencing the urinary excretion of 3′ 5′ adenosine monophosphate in humans. Journal of Clinical Endocrinology and Metabolism, 30, 316.
18.
WeltL. G., GitelmanH. (1965). Disorders of magnesium metabolism. Disease-a-month (May).
